Big tobacco invests big money in small Quebec City company

Photo: courtesy of Medicago

Medicago uses plant cells to generate H5N1 virus-like particles, which can be used to fight Avian Flu.

The board of directors at a small biopharmaceuti-cal company in Quebec City recently approved an investment of nearly $16 million from Phillip Morris International. The company, Medicago Inc., will use the investment from the inter-national tobacco company to pursue its development of a vaccine for the Avian flu.